- Home
- Products
- Customized FluoroAb™
- FOLR1
- Farletuzumab-iFluor 647
Farletuzumab-iFluor 647 (CAT#: ADC-FL-1539)
This product is comprised of an anti-FOLH1 monoclonal antibody (Farletuzumab) labeled with iFluor 647. iFluor 647 is a far-red-fluorescent dye and it's excitation/emission is 650/665 nm.
- TARGET
- ANTIBODY
- DYE
- Name
- FOLR1
- Alternative Names
- FOLH1; folate hydrolase (prostate-specific membrane antigen) 1; FOLH; glutamate carboxypeptidase 2; GCP2; GCPII; glutamate carboxylase II; glutamate carboxypeptidase II; NAALAD1; NAALAdase; PSM; PSMA; NAALADase I; membrane glutamate carboxypeptidase; cell
- Overview
- This gene encodes a type II transmembrane glycoprotein belonging to the M28 peptidase family. The protein acts as a glutamate carboxypeptidase on different alternative substrates, including the nutrient folate and the neuropeptide N-acetyl-l-aspartyl-l-glutamate and is expressed in a number of tissues such as prostate, central and peripheral nervous system and kidney. A mutation in this gene may be associated with impaired intestinal absorption of dietary folates, resulting in low blood folate levels and consequent hyperhomocysteinemia. Expression of this protein in the brain may be involved in a number of pathological conditions associated with glutamate excitotoxicity. In the prostate the protein is up-regulated in cancerous cells and is used as an effective diagnostic and prognostic indicator of prostate cancer. This gene likely arose from a duplication event of a nearby chromosomal region. Alternative splicing gives rise to multiple transcript variants encoding several different isoforms.
- Overview
- Humanized Anti-FOLR1 IgG1-kappa antibody, Farletuzumab
- Generic name
- Farletuzumab
- Species Reactivity
- Human
- Name
- iFluor 647
- Color
- Far-red
- Excitation⁄Emission (nm)
- 650/665
- Detection method
- Fluorescent
For Research Use Only. NOT FOR CLINICAL USE.
Related Products
- Anti-TNFRSF9 MAb (Clone 5)-iFluor® 514 Succinimidyl Ester (CAT#: WJY0-LS12291)
- Panitumumab-iFluor 546 (CAT#: ADC-FL-1157)
- Gantenerumab-iFluor 350 (CAT#: ADC-FL-091)
- Anti-CD19 MAb (Clone 14)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS14762)
- Anti-C5 MAb (Clone 13)-iFluor® 350 Succinimidyl Ester (CAT#: WJY0-LS140)
- Anti-FCER2 MAb (Clone 4)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2800)
- Anti-CMV MAb (Clone 9)-iFluor® 546 Succinimidyl Ester (CAT#: WJY0-LS15405)
- Anti-CD19 MAb (Clone 29)-iFluor® 405 Succinimidyl Ester (CAT#: WJY0-LS2473)
- Anti-CR2 MAb (Clone 5)-iFluor® 450 Succinimidyl Ester (CAT#: WJY0-LS7120)
- Bapineuzumab-Fluoresein (CAT#: ADC-FL-178)
Published Data
+ Submit Publications
Scientific Resources
Customer Reviews and FAQs
There are currently no Customer reviews or questions for ADC-FL-1539. Click the button above to contact us or submit your feedback about this product.
Quick Links
Other Products
Same Target
| CAT# | Product Name | Linker | Payload |
| ADC-W-1170 | Anti-FOLR1 (Farletuzumab)-MC-Vc-PAB-SN38 ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | SN-38 (7-ethyl-10-hydroxycamptothecin) |
| ADC-W-1168 | Anti-FOLR1 (Farletuzumab)-MC-MMAF ADC | MC (maleimidocaproyl) | MMAF |
| ADC-W-1171 | Anti-FOLR1 (Farletuzumab)-MC-Vc-PAB-DMEA-(PEG2)-duocarmycin SA ADC | MC-Vc-PAB-DMEA-(PEG2) | duocarmycin SA |
| ADC-W-1169 | Anti-FOLR1 (Farletuzumab)-MC-Vc-PAB-MMAE ADC | MC-Vc-PAB (maleimidocaproyl-valine-citrulline-p-aminobenzoyloxycarbonyl) | MMAE |
| ADC-W-516 | Anti-FOLR1-SPDB-DM4 ADC-5 | SPDB (N-succinimidyl-4-(2-pyridyldithio)butyrate) | DM4 (N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine) |
Online Inquiry
Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.
